Enovix Co. (NASDAQ:ENVX) Shares Acquired by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. lifted its position in shares of Enovix Co. (NASDAQ:ENVX) by 11.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 21,594 shares of the company’s stock after buying an additional 2,250 shares during the period. Atria Wealth Solutions Inc.’s holdings in Enovix were worth $235,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in ENVX. Private Advisor Group LLC increased its holdings in shares of Enovix by 23.6% during the 3rd quarter. Private Advisor Group LLC now owns 99,900 shares of the company’s stock worth $933,000 after buying an additional 19,056 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Enovix by 34.6% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 20,077 shares of the company’s stock worth $188,000 after buying an additional 5,162 shares during the last quarter. Gladstone Institutional Advisory LLC increased its holdings in shares of Enovix by 1.9% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 189,115 shares of the company’s stock worth $1,766,000 after buying an additional 3,525 shares during the last quarter. Clear Creek Financial Management LLC increased its holdings in shares of Enovix by 3.0% during the 3rd quarter. Clear Creek Financial Management LLC now owns 48,200 shares of the company’s stock worth $450,000 after buying an additional 1,400 shares during the last quarter. Finally, Janney Montgomery Scott LLC increased its holdings in shares of Enovix by 9.2% during the 3rd quarter. Janney Montgomery Scott LLC now owns 133,002 shares of the company’s stock worth $1,242,000 after buying an additional 11,242 shares during the last quarter. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Enovix Stock Down 1.3 %

Shares of Enovix stock opened at $8.92 on Friday. The business has a 50-day moving average of $11.22 and a 200-day moving average of $10.25. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61. The company has a market capitalization of $1.59 billion, a PE ratio of -6.15 and a beta of 1.87. Enovix Co. has a 1-year low of $5.70 and a 1-year high of $18.68.

Enovix (NASDAQ:ENVX) last announced its earnings results on Wednesday, February 19th. The company reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.01. The company had revenue of $9.72 million during the quarter, compared to the consensus estimate of $8.77 million. Enovix had a negative return on equity of 96.99% and a negative net margin of 963.17%. As a group, equities analysts forecast that Enovix Co. will post -1.01 EPS for the current fiscal year.

Insider Activity

In other news, CEO Rajendra K. Talluri sold 300,000 shares of the stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $9.35, for a total transaction of $2,805,000.00. Following the transaction, the chief executive officer now owns 2,045,301 shares of the company’s stock, valued at approximately $19,123,564.35. This trade represents a 12.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Betsy S. Atkins sold 75,000 shares of the stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total transaction of $729,750.00. Following the transaction, the director now directly owns 99,497 shares in the company, valued at $968,105.81. The trade was a 42.98 % decrease in their position. The disclosure for this sale can be found here. Insiders own 15.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ENVX. Cantor Fitzgerald reiterated an “overweight” rating and issued a $30.00 price target on shares of Enovix in a report on Thursday, February 20th. Craig Hallum lowered their price target on Enovix from $20.00 to $18.00 and set a “buy” rating for the company in a report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $20.30.

Enovix Profile

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.